Navigation Links
Possible treatment found for 'chemobrain'

The National Human Genome Research Institute (NHGRI), one of the National Institutes of Health (NIH), announced today that the Large-Scale Sequencing Research Network will target 13 more organisms as part of its ongoing effort to produce genomic data that will expand biological knowledge and improve human health.

The National Advisory Council for Human Genome Research (NACHGR), which is a federally chartered committee that advises NHGRI on program priorities and goals, recently approved a comprehensive plan that adds two new sets of sequencing targets. The strategy includes a mix of whole genome sequencing, genome mapping and sequencing of genomic regions chosen for their scientific merits.

“We want to set the stage for a greater understanding of the major biological innovations that have occurred throughout evolution, with emphasis on learning more about our own genome. Genomic information from a wide array of species already is proving useful in many areas of biomedical research that may benefit both humans and animals,?said Mark S. Guyer, Ph.D., director of NHGRI’s Division of Extramural Research.

The first group of targets consists of nine mammals. Eight mammals will be sequenced at low-density draft coverage, created by sequencing their genomes two times over. This sequencing strategy, begun last year on another set of mammals, is used primarily to identify features that are similar, or conserved, among the genomes of the human and other mammals. Sequences that have been conserved throughout evolution often reveal important functional regions of the human genome. Initial data show that using low-density sequencing for such comparisons is almost as effective as more costly, high-density sequencing. The eight mammals are: 13-lined ground squirrel (Spermophilis tridecemlineatus), megabat (Cynopterus species), microbat (Microchiroptera species), tree shrew (Tupaia belangeri), bushbaby (Otolemur garnetti), hyrax (Procavia capensis), pangolin ( Manis species) and sloth (Bradypus or Choloepus species).

The ninth mammal is the Northern white-cheeked gibbon (Nomascus leucogenys). This non-human primate species belongs to a major evolutionary branch that has not yet had the genome of any of its members sequenced. The gibbon genome is unique because it contains many chromosomal rearrangements, which makes it valuable for studying how such rearrangements have contributed to the evolution and speciation of humans and other non-human primates. To identify chromosomal rearrangements, researchers will need to sequence only small portions of the gibbon genome through a process known as Bacterial Artificial Chromosome (BAC)-end sequencing.

Also selected in the latest round were four non-mammalian organisms. Three of the organisms have been targeted for six-fold, or “high-quality draft,?sequencing. They are: M and S strains of a malaria-carrying mosquito (Anopheles gambiae) and a roundworm (Heterorhabditis bacteriophora). Researchers will also construct a physical map of the zebra finch (Taeniopygia guttata) genome, paving the way for later efforts to sequence selected regions of the songbird’s genome.

“Sequencing the genomes of a diverse set of organisms is a powerful tool to understand the biological processes at work in human health and illness,?said NHGRI Director Francis S. Collins, M.D., Ph.D. “Comparative genomics has proven to be one of the most effective strategies for revealing the important structural and functional elements of the human genome sequence.?/p>

The mosquito, Anopheles gambiae, is medically significant because it can harbor the malaria parasite, Plasmodium falciparum, and is the primary transmitter of the disease in Africa. Approximately 30 of 500 Anopheles species are known vectors of human malaria. Malaria afflicts up to 300 million people and kills more than 1 million people a year. In 2002, Celera Genomics completed a draft genome sequence of a laboratory strain o f Anopheles gambiae, a hybrid of two naturally occurring species, known as “M?and “S?strains, that can transmit malaria. Researchers expect that sequencing the genomes of the M and S strains, both of which are insecticide-resistant, will help to further efforts to combat malaria. The sequence data will also provide new insights into key structural and functional elements of the Anopheles genome.

The roundworm genome is important because its sequence will aid in comparative annotation of the genomes of other roundworms that have been sequenced, including that of Caenorhabditis elegans, one of the most important model systems for understanding animal development. In addition, Heterorhabditis bacteriophora is widely used as a biological control agent because it kills agricultural insect pests. Understanding its genome will increase insights into biological control, as well as into basic mechanisms of parasitism that may be applicable to parasites of humans.

The zebra finch was chosen because it is a major model system for understanding brain development, learning and memory. Because it is related to the chicken, whose genome has already been sequenced, it will be possible to leverage the chicken genome to get more insight from the zebra finch map.

It has been shown that most segments of the human genome originated long before humans themselves. Consequently, scientists will use the genome sequences of the non-mammalian animals to learn more about how, when and why the genomes of humans and other mammals came to be composed of certain DNA sequences, as well as to gain new insights into the organization of genomes.

Sequencing efforts will be carried out by the NHGRI-supported Large-Scale Sequencing Research Network, which consists of five centers: Agencourt Bioscience Corp., Beverly, Mass.; Baylor College of Medicine, Houston; the Broad Institute of MIT and Harvard, Cambridge, Mass.; The J. Craig Venter Science Institute, Rockville, Md.; a nd Washington University School of Medicine, St. Louis. Assignment of each organism to a specific center or centers will be determined at a later date.

NHGRI’s process for selecting sequencing targets begins with two working groups comprised of experts from across the research community. Each of the working groups is responsible for developing a proposal for a set of genomes to sequence that would advance knowledge in one of two important scientific areas: understanding the human genome and understanding the evolutionary biology of genomes. A coordinating committee then reviews the working groups?proposals, helping to fine-tune the suggestions and integrate them into an overarching set of scientific priorities. The recommendations of the coordinating committee are then reviewed and approved by NHGRI’s advisory council, which in turn forwards its recommendations regarding sequencing strategy to NHGRI leadership.

The genomes of a number of organisms have been or are being sequenced by the large-scale sequencing capacity developed by the Human Genome Project. These include the dog, the mouse, the rat, the chicken, the honey bee, ten fruit flies, the sea urchin, two puffer fish, two sea squirts, two roundworms, over a dozen fungi, baker’s yeast and the bacterium Escherichia coli. Organisms currently in the NHGRI sequencing pipeline include: macaque, orangutan, cow, platypus, red flour beetle, several additional species of fungi and domestic cat. A complete list of organisms and their sequencing status can be viewed at

To learn more about the rapidly growing field of comparative genomic analysis, go to: For the white papers on other organisms currently in NHGRI’s sequencing pipeline, go to: For more on NHGRI’s selection process for large-scale sequencing projects, go to:

High-resolution photos of the gibbon, bushbaby, 13- lined ground squirrel and other organisms in the Large-Scale Sequencing Program are available at:


Source:University of Cincinnati

Related biology news :

1. Stem Cells Found In Cerebellum; Possible Cell of Origin for Childhood Brain Tumors
2. Is it Possible to Change Prescribing Habits?
3. Possible brain hormone may unlock mystery of hibernation
4. Possible birthplace of malignant brain tumors identified
5. Protein discovery could unlock the secret to better TB treatment
6. Topical treatment shown to inhibit HIV and herpes simplex virus infection
7. Weizmann Institute scientists develop a new approach for directing treatment to metastasized prostate cancer in the bones.
8. Researchers add new tool to tumor-treatment arsenal
9. Potential treatments for neurofibromatosis
10. Nanoparticles offer new hope for detection and treatment
11. Technique may allow cancer patients to freeze eggs, preserving fertility before starting treatment
Post Your Comments:

(Date:11/9/2015)... 2015 ... "Global Law Enforcement Biometrics Market 2015-2019" ... ) has announced the addition ... Market 2015-2019" report to their offering. ... ) has announced the addition of ...
(Date:11/2/2015)... Calif. , Nov. 2, 2015  SRI International ... million to provide preclinical development services to the National ... contract, SRI will provide scientific expertise, modern testing and ... variety of preclinical pharmacology and toxicology studies to evaluate ... --> The PREVENT Cancer Drug Development Program ...
(Date:10/29/2015)... 2015 Daon, a global leader in mobile ... a new version of its IdentityX Platform , ... America have already installed IdentityX v4.0 and ... FIDO UAF certified server component as an ... FIDO features. These customers include some of the largest ...
Breaking Biology News(10 mins):
(Date:11/25/2015)... , November 25, 2015 ... Report is a professional and in-depth study on ...      (Logo: ) , ... the industry including definitions, classifications, applications and industry ... for the international markets including development trends, competitive ...
(Date:11/24/2015)... , Nov. 24, 2015 Halozyme Therapeutics, Inc. (NASDAQ: ... in New York on Wednesday, December 2 ... Torley , president and CEO, will provide a corporate overview. ... York at 1:00 p.m. ET/10:00 a.m. PT . ... relations, will provide a corporate overview. --> th ...
(Date:11/24/2015)... -- Clintrax Global, Inc., a worldwide provider of clinical research services headquartered ... the company has set a new quarterly earnings record in Q3 ... posted for Q3 of 2014 to Q3 of 2015.   ... , with the establishment of an Asia-Pacific ... United Kingdom and Mexico , with ...
(Date:11/24/2015)... 2015 --> ... released by Transparency Market Research, the global non-invasive prenatal ... of 17.5% during the period between 2014 and 2022. ... Industry Analysis, Size, Volume, Share, Growth, Trends and Forecast ... market to reach a valuation of US$2.38 bn by ...
Breaking Biology Technology: